Literature DB >> 3300615

Topical vs systemic gentamicin penetration into the human cornea and aqueous humor.

M S Insler, C J Helm, W J George.   

Abstract

Twenty-two patients undergoing penetrating keratoplasty received either topical fortified gentamicin (13.6 mg/mL) or a loading dose of intramuscular gentamicin before surgery. Cornea and aqueous humor samples were obtained and assayed by radioimmunoassay for gentamicin. In the topical group, the average gentamicin levels in the cornea and aqueous were 16.2 micrograms/g and 0.3 microgram/mL, respectively. Parenteral drug levels were less variable and averaged 6.1 micrograms/g in the cornea and 0.4 microgram/mL in the aqueous. Although this study demonstrates that parenteral therapy can be used to deliver adequate drug levels to the cornea, it requires far more antibiotic and subjects the patient to potentially toxic systemic side effects. Therefore, topical administration is the preferred route of delivery of antibiotic to the cornea.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300615     DOI: 10.1001/archopht.1987.01060070058028

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  6 in total

Review 1.  Treatment of ocular infections with topical antibacterials.

Authors:  J P Leeming
Journal:  Clin Pharmacokinet       Date:  1999-11       Impact factor: 6.447

2.  Efficacy of iontophoresis in the rat cornea.

Authors:  J Frucht-Pery; A Solomon; R Doron; P Ever-Hadani; O Manor; M Shapiro
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-12       Impact factor: 3.117

Review 3.  Pharmacokinetic considerations in the treatment of bacterial keratitis.

Authors:  M C Callegan; R J O'Callaghan; J M Hill
Journal:  Clin Pharmacokinet       Date:  1994-08       Impact factor: 6.447

4.  Ocular pharmacokinetics of tobramycin. A comparative radioimmunoassay and microbiological assay.

Authors:  S Desai
Journal:  Int Ophthalmol       Date:  1993-08       Impact factor: 2.031

5.  Human corneal stromal tissue concentration after consecutive doses of topically applied 3.3% vancomycin.

Authors:  M Cahane; G J Ben Simon; I S Barequet; A Grinbaum; L Diamanstein-Weiss; O Goller; E Rubinstein; I Avni
Journal:  Br J Ophthalmol       Date:  2004-01       Impact factor: 4.638

6.  Intraocular pressure changes: an important determinant of the biocompatibility of intravitreous implants.

Authors:  Ling Zou; Ashwin Nair; Hong Weng; Yi-Ting Tsai; Zhibing Hu; Liping Tang
Journal:  PLoS One       Date:  2011-12-14       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.